The impact of implementation of oral dextrose gel on the incidence of multiple hypoglycemia events in the well newborn nursery

J Perinatol. 2024 Nov;44(11):1635-1639. doi: 10.1038/s41372-024-02032-z. Epub 2024 Jun 26.

Abstract

Objective: Evaluate the impact of 40% oral dextrose gel (DG) for management of neonatal hypoglycemia (NH) on the incidence of multiple hypoglycemic events in the well-baby nursery.

Study design: A retrospective chart review of 738 at-risk infants in 2 cohorts before (Cohort 1) and after (Cohort 2) DG implementation. Primary outcome was the incidence of ≥2 hypoglycemic episodes. Secondary outcomes were number of lowest median glucose level, and incidence of NICU admission.

Results: There were 384 and 354 at-risk newborns in Cohorts 1 & 2. The incidence of developing ≥2 hypoglycemia episodes significantly decreased following DG implementation [62(42.5%) vs 29(25.9%), p = 0.0058]. There were no differences in lowest glucose level [37 (14-45) vs 37 (10-45), p = 0.31], and NICU admission rate [31 (21.2%) vs 21 (18.8%), p = 0.62].

Conclusions: Implementation of DG lowers the incidence of subsequent hypoglycemia episodes.

MeSH terms

  • Administration, Oral
  • Blood Glucose* / analysis
  • Female
  • Gels*
  • Glucose* / administration & dosage
  • Glucose* / adverse effects
  • Humans
  • Hypoglycemia* / epidemiology
  • Hypoglycemia* / prevention & control
  • Incidence
  • Infant, Newborn
  • Intensive Care Units, Neonatal*
  • Male
  • Retrospective Studies
  • Sweetening Agents / administration & dosage
  • Sweetening Agents / adverse effects

Substances

  • Gels
  • Glucose
  • Blood Glucose
  • Sweetening Agents